MedPath
NMPA Approval

Insulin Degludec and Insulin Aspart Injection

国药准字S20240031

July 30, 2024

Drug Information

德谷门冬双胰岛素注射液

惠优加

注射剂

3ml:300单位(笔芯)

生物制品

July 30, 2024

Company Information

Applicant Company

吉林省梅河口市爱民东大街1088号

Manufacturing Company

吉林省梅河口市爱民东大街1088号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

德谷门冬双胰岛素注射液 - NMPA 批准文号 | MedPath